FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809282407> ?p ?o ?g. }

• W2809282407 endingPage "28804" @default.
• W2809282407 startingPage "28799" @default.
• W2809282407 abstract "Minimal change disease (MCD) accounts for 15% of adult nephrotic syndrome (NS) cases. Adult-MCD patients may have more severe clinical features than pediatric patients. In children, Rituximab (RTX) has been used since 2006 to treat frequently relapsing NS. In adults, data about the efficacy of RTX for MCD are limited. We report our experience on the use of RTX in adult biopsy-proven MCD. Our series includes 6 adult patients (2 males and 4 females), age 45-73 years, treated with RTX (4 weekly doses of 375 mg/m2). Proteinuria decreased from 11,2 (23-4.8) g/24 hours to 0.6 (0-2) g/24 hours after 6 months, and to 0.4 (0-1, 4) g/24 h in the 4 pts with the longer follow-up. Creatinine decreased from 1.95 (0.5-5) mg/dl to 0.88 (0.6-1.3) mg/l. Five patients achieved a complete renal remission, while in 1 pt proteinuria decreased by 75%. RTX successfully depleted CD19 lymphocytes in 100% of pts for at least 6 months. No clinically relevant adverse events have been observed. This case series shows a remarkable efficacy of RTX in treatment of MCD. RTX can be an attractive alternative both in recurrent forms and in induction-therapy of MCD. RTX may be preferentially used in patients at a high risk of development of the adverse effects of corticosteroids and should be considered as an alternative option in patients with recurrent NS. Additional data are needed to inform clinical practice on how best to use RTX in this patient population, so that definitive randomized trials can be planned." @default.
• W2809282407 created "2018-06-29" @default.
• W2809282407 creator A5012705049 @default.
• W2809282407 creator A5017039749 @default.
• W2809282407 creator A5024647892 @default.
• W2809282407 creator A5030143277 @default.
• W2809282407 creator A5030770013 @default.
• W2809282407 creator A5032751344 @default.
• W2809282407 creator A5066865082 @default.
• W2809282407 creator A5086035399 @default.
• W2809282407 date "2018-06-22" @default.
• W2809282407 modified "2023-10-16" @default.
• W2809282407 title "Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome" @default.
• W2809282407 cites W1138285298 @default.
• W2809282407 cites W1583849384 @default.
• W2809282407 cites W1697556097 @default.
• W2809282407 cites W1921319607 @default.
• W2809282407 cites W1969817709 @default.
• W2809282407 cites W1981351208 @default.
• W2809282407 cites W1983112486 @default.
• W2809282407 cites W1986784482 @default.
• W2809282407 cites W1988018442 @default.
• W2809282407 cites W1988812807 @default.
• W2809282407 cites W2004431007 @default.
• W2809282407 cites W2043782712 @default.
• W2809282407 cites W2051978504 @default.
• W2809282407 cites W2052862354 @default.
• W2809282407 cites W2064739203 @default.
• W2809282407 cites W2076489036 @default.
• W2809282407 cites W2104254325 @default.
• W2809282407 cites W2105893193 @default.
• W2809282407 cites W2107668112 @default.
• W2809282407 cites W2124483937 @default.
• W2809282407 cites W2124838654 @default.
• W2809282407 cites W2132946747 @default.
• W2809282407 cites W2138059907 @default.
• W2809282407 cites W2281776699 @default.
• W2809282407 cites W2493243615 @default.
• W2809282407 cites W2535929519 @default.
• W2809282407 cites W2553445420 @default.
• W2809282407 cites W2579770386 @default.
• W2809282407 cites W2600340746 @default.
• W2809282407 cites W2604747147 @default.
• W2809282407 cites W2619614038 @default.
• W2809282407 cites W96995753 @default.
• W2809282407 doi "https://doi.org/10.18632/oncotarget.25612" @default.
• W2809282407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6034752" @default.
• W2809282407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29989000" @default.
• W2809282407 hasPublicationYear "2018" @default.
• W2809282407 type Work @default.
• W2809282407 sameAs 2809282407 @default.
• W2809282407 citedByCount "21" @default.
• W2809282407 countsByYear W28092824072020 @default.
• W2809282407 countsByYear W28092824072021 @default.
• W2809282407 countsByYear W28092824072022 @default.
• W2809282407 countsByYear W28092824072023 @default.
• W2809282407 crossrefType "journal-article" @default.
• W2809282407 hasAuthorship W2809282407A5012705049 @default.
• W2809282407 hasAuthorship W2809282407A5017039749 @default.
• W2809282407 hasAuthorship W2809282407A5024647892 @default.
• W2809282407 hasAuthorship W2809282407A5030143277 @default.
• W2809282407 hasAuthorship W2809282407A5030770013 @default.
• W2809282407 hasAuthorship W2809282407A5032751344 @default.
• W2809282407 hasAuthorship W2809282407A5066865082 @default.
• W2809282407 hasAuthorship W2809282407A5086035399 @default.
• W2809282407 hasBestOaLocation W28092824071 @default.
• W2809282407 hasConcept C126322002 @default.
• W2809282407 hasConcept C197934379 @default.
• W2809282407 hasConcept C2777747828 @default.
• W2809282407 hasConcept C2778415529 @default.
• W2809282407 hasConcept C2778930706 @default.
• W2809282407 hasConcept C2779338263 @default.
• W2809282407 hasConcept C2779561371 @default.
• W2809282407 hasConcept C2780091579 @default.
• W2809282407 hasConcept C2780653079 @default.
• W2809282407 hasConcept C71924100 @default.
• W2809282407 hasConcept C90924648 @default.
• W2809282407 hasConceptScore W2809282407C126322002 @default.
• W2809282407 hasConceptScore W2809282407C197934379 @default.
• W2809282407 hasConceptScore W2809282407C2777747828 @default.
• W2809282407 hasConceptScore W2809282407C2778415529 @default.
• W2809282407 hasConceptScore W2809282407C2778930706 @default.
• W2809282407 hasConceptScore W2809282407C2779338263 @default.
• W2809282407 hasConceptScore W2809282407C2779561371 @default.
• W2809282407 hasConceptScore W2809282407C2780091579 @default.
• W2809282407 hasConceptScore W2809282407C2780653079 @default.
• W2809282407 hasConceptScore W2809282407C71924100 @default.
• W2809282407 hasConceptScore W2809282407C90924648 @default.
• W2809282407 hasIssue "48" @default.
• W2809282407 hasLocation W28092824071 @default.
• W2809282407 hasLocation W28092824072 @default.
• W2809282407 hasLocation W28092824073 @default.
• W2809282407 hasLocation W28092824074 @default.
• W2809282407 hasLocation W28092824075 @default.
• W2809282407 hasLocation W28092824076 @default.
• W2809282407 hasOpenAccess W2809282407 @default.
• W2809282407 hasPrimaryLocation W28092824071 @default.
• W2809282407 hasRelatedWork W1487881706 @default.

• next